Here are relevant reports on : pencil-market
-
Global Human Immunodeficiency Virus (HIV) Market (2012 – 2017)
Human immunodeficiency virus (HIV) is a retrovirus which causes Acquired Immunodeficiency syndrome (AIDS) in humans, a condition where immune system fails, leading to opportunistic infections that is life threatening. HIV infection occurs via transfer of blood, semen, vaginal fluid, pre-ejaculate, or breast milk and major routes of infection transmission are unsafe sex, contaminated needles, perinatal transmission, breast milk and infected blood products.
- Published: January 2025
- Price: $ 4950
- TOC Available:
-
Autoimmune Treatment Market (2009 - 2014)
The report sizes the market for the diagnosis and therapeutic technologies for the auto immune diseases. It also tracks the advances in the technologies along with the profiles and strategies of the key players in this market. The report highlights the new approaches being pursued in this market.
- Published: September 2009
- Price: $ 4950
- TOC Available:
-
Global Weight Loss and Diet Management Market (2009 - 2014)
Obesity and weight gain issues have always been a major concern impacting the health and fitness of the individuals. Increasing awareness levels among the appearance and calorie conscious consumers has opened up new avenues and opportunities to this market. The rate of new product entry in the weight management segment is significantly high, necessitating industry participants to adopt proactive strategies and keep ahead of competition.
- Published: July 2009
- Price: $ 4950
- TOC Available:
-
Thin-Film Photovoltaic Market by Material (Cadmium Telluride, Copper Indium Gallium Selenide, Amorphous Silicon, Perovskite, and Organic PV), Type (Rigid, and Flexible), Component (Module, Inverter, and BOS), End Use & Region - Global Forecast to 2029
The thin-film photovoltaic market is expected to grow from USD 6.2 billion in 2024 to USD 12.4 billion by 2029, at a compound annual growth rate (CAGR) of 15.1% during the forecast period.The key players KANEKA CORPORATION (Japan), First Solar (US), Ascent Solar Technologies, Inc. (US), Hanwha Qcells (South Korea), Oxford Photovoltaics Ltd. (UK), and SHARP CORPORATION (Japan). JA SOLAR Technology Co., Ltd. (China), AVANCIS GmbH (Germany), MiaSole (US), Solbian (Italy), SOLARA (Germany), Custom Solar BIPV Panels – MetSolar (Lithuania), Enecom S.r.l. (Italy), TRONY (China), NanoPV Solar Inc. (New Jersey), QS SOLAR (China), Heliatek (Germany), Wuxi Suntech Power Co., Ltd. (China), Jinko Solar (China), Trinasolar (China), Panasonic Holdings Corporation (Japan), Sol Voltaics (Sweden), Tandem PV, Inc. (US), SOLAR FRONTIER K.K. (Japan), and REC Solar Holdings AS (Norway) .
- Published: August 2024
- Price: $ 4950
- TOC Available:
-
Concentrated Photovoltaic Market By Concentration levels (High and Low), By Technology (Refractor and Reflectors), By Application (Utility-Scale, Commercial, and Others) & By Geography- Global Trends and Forecast to 2019
This report estimates the concentrated photovoltaic market in terms of value. The global concentrated photovoltaic market is segmented based on their concentration levels, which include high, medium, and low. The market is further segmented on the basis of regions such as Asia-Pacific, Europe, the Middle East & Africa, and Americas as well as on the basis of technologies such as refractors and reflectors. This has been further split into major countries for the respective geographies.
- Published: June 2014
- Price: $ 4950
- TOC Available:
-
Global Waste-To-Energy Market By Geography, Technology, Applications Market Trends And Forecasts
Waste-to-energy (WtE) is the process wherein waste is treated to generate energy. This report looks at the WtE current and emerging technologies, key players in the market and the commercialization of such technologies.
- Published: March 2011
- Price: $ 4950
- TOC Available:
-
Clean Coal - Advanced Technologies and Global Market (2010 - 2015)
Coal generates nearly 40% of the global energy needs. It is one of the most commonly used but also one of the dirtiest fuels. Clean Coal Technology (CCT) reduces coal’s contribution to global warming, and enhances the amount of energy that coal generates. The report reviews these technologies and the commercial market associated with them.
- Published: January 2025
- Price: $ 4950
- TOC Available:
-
Life Science Instrumentation Market by Technology (Spectroscopy, Chromatography, Immunoassay, NGS, PCR, Microscopy), Application (Diagnostic, Clinical), End User (Pharma, Agriculture & Food Industry, Hospitals, Diagnostic Labs) & Region - Global Forecast to 2028
The global life science instrumentation market, valued at US$50.9B in 2022, is forecasted to grow at a 6.1% CAGR, reaching US$54.9B by 2023 and US$73.9B by 2028. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
- Published: May 2023
- Price: $ 4950
- TOC Available:
-
Bioinformatics Market by Product & Service (Knowledge Management Tools, Bioinformatics Platforms, Data Analysis, Structural Analysis, Services), Applications (Genomics, Proteomics, Transcriptomics), Sectors (Medical, Animal) & Region - Global Forecast to 2027
The global bioinformatics market in terms of revenue was estimated to be worth $10.1 billion in 2022 and is poised to reach $18.7 billion by 2027, growing at a CAGR of 13.0% from 2022 to 2027. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
- Published: December 2022
- Price: $ 4950
- TOC Available:
-
Biosimilars Market by Drug Class (Drug Class (Monoclonal Antibodies (Adalimumab, Infliximab, Rituximab, Trastuzumab), Insulin, Erythropoietin, Anticoagulants. rhGH), Indication, Region – Global Forecast to 2028
Biosimilars market growth is primed to transition from 29.4 billion in 2023 to USD 66.9 billion by 2028, showcasing a strong CAGR of 17.8%. This market is driven by increasing demand for cost-effective treatments amidst rising chronic disease rates and the patent expirations of major biologics. Key trends include the rapid approval and adoption of biosimilars, particularly in oncology.
- Published: June 2023
- Price: $ 4950
- TOC Available:
Records 1 to 10 of 50
